购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • DNA/RNA Synthesis
    (1)
  • Others
    (2)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 5日内发货
    (3)
  • 6-8周
    (2)
筛选
搜索结果
TargetMol产品目录中 "

nucleolus

"的结果
  • 抑制剂&激动剂
    3
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    3
    TargetMol | Recombinant_Protein
  • 染料试剂
    1
    TargetMol | Dye_Reagents
  • BMH-21
    BMH21
    T1767896705-16-1
    BMH-21 是一种小分子 DNA 嵌入剂,可结合核糖体 DNA 并抑制 RNA 聚合酶 I (Pol I) 转录,具有抗癌活性。
    • ¥ 158
    In stock
    规格
    数量
  • Diazaborine
    Pkf-84474, Pkf 84.474, Pkf 84474, Diazaborine compound 2b18
    T2716522959-81-5
    Diazaborine inhibits maturation of rRNAs for the large ribosomal subunit. Diazaborine blocks ribosome biogenesis by inhibiting the AAA-ATPase Drg1. Diazaborine treatment causes, within minutes, a rapid redistribution of the protein from the nucleolus to t
    • ¥ 10600
    6-8周
    规格
    数量
  • Pidnarulex HCl
    T699082101314-20-7
    Pidnarulex HCl is the salt form of CX-5461, a first-in-class non-genotoxic small molecule targeted inhibitor of RNA polymerase I (Pol I) that activates the p53 pathway without causing DNA damage. CX-5461 selectively inhibits rRNA synthesis by Pol I in the nucleolus, but does not inhibit mRNA synthesis by RNA Polymerase II (Pol II) and does not inhibit DNA replication or protein synthesis. Inhibition of Pol I results in nucleolar stress and release of ribosomal proteins (RP) from the nucleolus. The RP bind to Mdm2 and liberate p53 to orchestrate apoptosis in cancer cells. CX-5461 demonstrates a favorable preclinical profile, potently and selectively kills cancer cells, demonstrates robust in vivo efficacy in multiple models, and has demonstrated oral bioavailability in multiple species.
    • ¥ 10600
    6-8周
    规格
    数量